Mechanistic and toxicokinetic data reducing uncertainty in risk assessment

Toxicology Letters

Volumn 138, Issue 1-2, 2003, Pages 1-8

  Greim, H ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Chlorobenzene; Covalent binding; Ethylene; Risk assessment; Styrene; Toxicokinetic modeling

Indexed keywords

CHLOROBENZENE; CYTOCHROME P450; ETHYLENE; ETHYLENE OXIDE; GLUTATHIONE TRANSFERASE; HYDROLASE; STYRENE;

ARTICLE; CARCINOGENICITY; COVALENT BOND; ENZYME ACTIVITY; GENOTOXICITY; HUMAN; LIVER TOXICITY; MUTAGENICITY; NONHUMAN; PRIORITY JOURNAL; RISK ASSESSMENT; SPECIES DIFFERENCE; TOXICOKINETICS;

ANIMALS; CARCINOGENS; CHLOROBENZENES; DOSE-RESPONSE RELATIONSHIP, DRUG; ETHYLENE OXIDE; ETHYLENES; HUMANS; MICE; NO-OBSERVED-ADVERSE-EFFECT LEVEL; RATS; RISK ASSESSMENT; SPECIES SPECIFICITY; STYRENE; UNCERTAINTY;

RODENTIA;

EID: 0037452435     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-4274(02)00408-3     Document Type: Article

References (37)

1. ACGIH: American Conference of Governmental Indusrial Hygienists, 2002. Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs). ACGIH, Technical Affairs Office, Cincinnati, OH 45240.
2. Boogaard P.J., de Kloe K.P., Wong B.A., Sumner S.C., Watson W.P., van Sittert N.J. Quantification of DNA adducts formed in liver, lungs, and isolated lung cells of rats and mice exposed to (14)C-styrene by nose-only inhalation. Toxicol. Sci. 57:2000;203-216.
3. BUA: GDCh-Advisory Committee on Existing Chemicals. 1990. BUA Report. Chlorbenzol. BUA-Stoffbericht 54, VCH Weinheim.
4. Cruzan G., Cushman J.R., Andrews L.S., Granville G.C., Johnson K.A., Hardy C.J., Coombs D.W., Mullins P.A., Brown W.R. Chronic toxicity/oncogenicity study of styrene in CD rats by inhalation exposure for 104 weeks. Toxicol. Sci. 46:1998;266-281.
5. Cruzan G., Cushman J.R., Andrews L.S., Granville G.C., Johnson K.A., Bevan C., Hardy C.J., Coombs D.W., Mullins P.A., Brown W.R. Chronic toxicity/oncogenicity study of styrene in CD-1 mice by inhalation exposure for 104 weeks. J. Appl. Toxicol. 21:2001;185-198.
6. Csanády G.A., Kessler W., Filser J.G. Carcinogenic risk estimates for inhaled styrene based on the body burden of its metabolite styrene-7,8-oxide. Naunyn-Schmiedeberg's Arch. Pharmacol. (Suppl. 351):1995;122.
7. Csanády G.A., Denk B., Pütz C., Kreuzer P.E., Kessler W., Baur C., Gargas M.L., Filser J.G. A physiological toxicokinetic model for exogenous and endogenous ethylene and ethylene oxide in rat, mouse, and human: Formation of 2-hydroxyethyl adducts with hemoglobin and DNA. Toxicol. Appl. Pharmacol. 165:2000;1-26.
8. Csanády G.A., Filser J.G. The relevance of physical activity for the kinetics of inhaled gaseous substances. Arch. Toxicol. 74:2001;663-672.
9. Guenthner T.M., Luo G. Investigation of the role of the 2′,3′-epoxidation pathway in the bioactivation and genotoxicity of dietary allylbenzene analogs. Toxicology. 160:2001;47-58.
10. Ehrenberg L., Ostermann-Golkar S., Segerbäck D., Svenson K., Calleman C.J. Evaluation of genetic risks of alkylating agents. III. Alkylation of hemoglobin after metabolic conversion of ethene to ethene oxide in vivo. Mutat. Res. 45:1977;175-184.
11. EPA: Environmental Protection Agency: Proposed Guidelines for Carcinogenic Risk Assessment., 1996. Office of Research and Development. US Environmental Protection Agency. Washington, DC. EPA/600/P-92/003C, April 1996, Federal. Register 61, 17960-18011.
12. European Commission, EC, 1996. Guidelines for Setting Specific Concentration Limits for Carcinogens in Annex I of Directive 67/548/EEC. Inclusion of Potency Considerations. Commission Working Group on the Classification and Labelling of Dangerous Substances.
13. Filser J., Bolt H.M. Inhalation pharmacokinetics based on gas uptake studies. VI. Comparative evaluation of ethylene oxide and butadiene monoxide as exhaled reactive metabolites of ethylene and 1,3-butadiene in rats. Arch. Toxicol. 55:1984;219-223.
14. Filser J.G., Denk B., Törnquist M., Kessler W., Ehrenberg L. Pharmacokinetics of ethylene in man: body burden with ethylene oxide and hydroxyethylation of hemoglobin due to endogenous and environmental ethylene. Arch. Toxicol. 66:1992;157-163.
15. Filser, J.G., Kessler, W., Csanády, G.A., 1993. Different approaches to estimate the carcinogenic risk of styrene based on animal studies. The SIRC Review 3, 54.
16. Filser J.G., Kessler W., Csanády G.A. Estimation of a possible tumorigenic risk of styrene from daily intake via food and ambient air. Toxicol. Lett. 126:2002;1-18.
17. Girard M.M.R., Tolot F., Martin P., Bourret J. Hémopathies graves et exposition à des dérivés chlorés du bezène (à propos de 7 cas). J. Med. Lyon. 50:1969;771-773.
18. Greim H. Ethylene. Occupational Toxicants. 10:1998;91-107 Wiley-VCH, Weinheim.
19. Greim H. Chlorobenzene. Occupational Toxicants. 12:1999;103-127 Wiley-VCH, Weinheim.
20. Henschler D. Styrol. Toxikologisch-arbeitsmedizinische Begründungen von MAK-Werten. 13:1987;Lieferung, VCH-Verlag, Weinheim.
21. Hynes D.E., DeNicola D.B., Carlson G.P. Metabolism of styrene by mouse and rat isolated lung cells. Toxicol. Sci. 51:1999;195-201.
22. IARC: International Agency for Research of Cancer, 1997. IARC Monographs, Preamble, 12. Evaluation, Vol. 68, Lyon.
23. IARC: International Agency for Research on Cancer. 1994. Some industrial chemicals. IARC Monographs, Volume 60, Lyon.
24. Knecht U., Woitowitz H.J. Human toxicokinetics of inhaled monochlorobenzene: latest experimental findings regarding re-evaluation of the biological tolerance value. Int. Arch. Occup. Environ. Health. 73:2000;543-554.
25. Kolstad H.A., Juel K., Olsen J., Lynge E. Exposure to styrene and chronic health effects: mortality and incidence of solid cancers in the Danish reinforced plastics industry. Occup. Environ. Med. 52:1995;320-327.
26. Lorenz J., Glatt H.R., Fleischmann R., Ferlinz R., Oesch F. Drug metabolism in man and its relationship to that in three rodent species: monooxygenase, epoxide hydrolase and glutathione S-transferase activities in subcellular fractions of lung and liver. Biochem. Med. 32:1984;43-56.
27. Neumann H.G., Thielmann H.W., Filser J.G., Gelbke H.P., Greim H., Kappus H., Norpoth K.H., Reuter U., Vamvakas S., Wardenbach P., Wichmann H.E. Vorschläge zur Änderung der Einstufung krebserzeugender Arbeitsstoffe. Arbeitsmed Sozialmed Umweltmed. 32:1997;298-304.
28. Neumann H.G., Thielmann H.W., Filser J.G., Gelbke H.P., Greim H., Kappus H., Norpoth K.H., Reuter U., Vamvakas S., Wardenbach P., Wichmann H.E. Changes in the classification of carcinogenic chemicals in the work area. J. Cancer Res. Clin. Oncol. 124:1998;661-669.
29. Oberste-Frielinghaus, M., Dhawan-Robl, M., Pütz, C., Csanády, G.A., Filser, J.G., 2000. Styrene metabolism and glutathione depletion in lungs of rats and mice. Abstract, Sixth International Symposium on Biological Reactive Intermediates, Paris.
30. Oberste-Frielinghaus, M., Dhawan-Robl, M., Pütz, C., Csanády, G.A., Filser, J.G., 1999. Metabolism of styrene and racemic styrene-7,8-oxide in microsomes and cytosol of lung obtained from mouse, rat and human. Naunyn-Schmiedeberg′s Arch Pharmacol: R157.
31. OECD, Organisation for Economic Co-operation and Development, 1995a. Classification Systems on Carcinogens in OECD Countries-Similarities and Differences. Prepared by Norway and The Netherlands. Oslo and Bilthoven, Final Report, September, 1995.
32. OECD, Organisation for Economic Co-operation and Development, 1995b. Report from the OECD, Working Group on Harmonization of Classification and Labeling of Carcinogens, Washington DC, October 1995. 17-18.
33. Osterman-Golkar S., Christakopoulos A., Zorec V., Svensson K. Dosimetry of styrene 7,8-oxide in styrene- and styrene oxide-exposed mice and rats by quantification of haemoglobin adducts. Chem-Biol. Interact. 95:1995;79-87.
34. Sanner T., Dybing E., Kroese D., Roelfzema H., Hardeng S. Carcinogen classification systems: similarities and differences. Reg. Toxicol. Pharmacol. 23:1996;128-138.
35. Somerovská M., Jahnová E., Tulinská J., Zámecniková M., Sarmanová J., Terenová A., Vodicková L., Lisková A., Vallová B., Soucek P., Hemminki K., Norppa H., Hirvonen A., Tates A.D., Fuortes L., Dusinská M., Vodická P. Biomonitoring of occupational exposure to styrene in a plastics lamination plant. Mutat. Res. 428:1999;255-269.
36. Vodicka P., Bastlova T., Vodickova I., Peterkova K., Lambert B., Hemminki K. Biomarkers of styrene exposure in lamination workers: levels of O6-guanine DNA adducts, DNA strand breaks and mutant frequencies in the hypoxanthine guanine phosphoribosyltransferase gene in T-lymphocytes. Carcinogenesis. 16:1995;1473-1481.
37. Vodicka P., Tvrdik T., Osterman-Golkar S., Vodickova L., Peterkova K., Soucek P., Sarmanova J., Farmer P.B., Granath F., Lambert B., Hemminki K. An evaluation of styrene genotoxicity using several biomarkers in a 3-year follow-up study of hand-lamination workers. Mutat. Res. 445:1999;205-224.